☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Sanofi
Sanofi Reports P-II Study Results of Frexalimab for the Treatment of Relapsing Multiple Sclerosis
June 1, 2023
PharmaShots Weekly Snapshots (May 08 - 12, 2023)
May 13, 2023
Sanofi Reports P-IIIb Trial (HARMONIE) Results of Nirsevimab for the Prevention of Hospitalizations due to RSV-Related LRTD
May 12, 2023
Sanofi and Regeneron Report P-III Trial (PRIME) and (PRIME2) Results of Dupixent (dupilumab) for the Treatment of Prurigo Nodulari...
May 9, 2023
Sanofi’s Dupixent (dupilumab) Receives Health Canada’s Approval for Adults and Adolescent Patients Aged ≥12 Years with Eosinophili...
May 5, 2023
Top Performing Drug – Dupixent (April Edition)
April 26, 2023
Load more...
Back to Home